The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients
Date
2021Author
Karadag, S. G.
Ozdel, S.
Yener, G. Otar
Demir, F.
Ozturk, K.
Cakan, M.
Ayaz, N. Aktay
Baglan, E.
Sozeri, B.
Sonmez, H. E.
Metadata
Show full item recordAbstract
Objective. To determine the feasibility of withdrawing canakinumab (CAN) in a large cohort of paediatric patients with colchicine-resistant familial Mediterranean fever (crFMF).
Collections
- Makale [92796]